单核细胞增多症诊断市场增长、规模、份额、趋势、关键参与者分析及预测至 2031 年

  • Report Code : TIPRE00019689
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 210
Buy Now

单核细胞增多症诊断市场规模预计将从 2023 年的 1.5144 亿美元增至 2031 年的 2.2215 亿美元。预计 2023-2031 年期间该市场的复合年增长率为 4.9%。预测期内,分子诊断技术的进步可能会带来新的市场趋势。

单核细胞增多症诊断市场分析

根据联合国的定义,青少年人口(10-19岁)正经历从童年到成年的过渡期,在此期间,青少年人口经历了显著的成长和发展。根据联合国儿童基金会(UNICEF)的数据,全球有13亿青少年,占世界总人口的16%。单核细胞增多症通常被称为“接吻病”,主要影响青少年和年轻人。随着青少年人口的增长,这种疾病的发病率也在上升。爱泼斯坦-巴尔病毒(EBV)是这种疾病最常见的病因,通常在接吻或共享饮料时通过唾液传播。

医疗保健提供者对有效的诊断测试的需求很高,这些测试可用于识别和确认青少年单核细胞增多症。单核细胞增多症检测、EBV 抗体检测和咽喉培养是这种疾病的既定诊断方法。单核细胞增多症检测涉及检测血液中的特定抗体,而 EBV 抗体检测则专门用于检测抗 EBV 抗体。许多医疗保健提供者还专注于提供即时检测和远程医疗服务,这些服务专门针对喜欢快速、在家诊断的便利的年轻患者。这些创新简化了及时诊断,减少了获取的障碍并提高了总体检测率。快速识别单核细胞增多症病例的能力可以更好地管理患者,并最大限度地减少疾病对学业和社会生活的影响。因此,青少年患单核细胞增多症的风险很高,导致对诊断产品和服务的需求很大。

单核细胞增多症诊断市场概览

由于青少年人群患病风险高,以及人们对该疾病的健康意识和知识不断提高,单核细胞增多症诊断市场正在迅速扩大。市场上的知名企业正专注于创新和合作,以提高产品可用性。此外,分子诊断技术的进步预计将在未来几年带来新的市场趋势。然而,现有诊断测试的低准确性阻碍了单核细胞增多症诊断市场的增长。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

单核细胞增多症诊断市场:

Mononucleosis Diagnostic Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

单核细胞增多症诊断市场驱动因素和机遇

人们对单核细胞增多症的健康意识和知识不断提高,推动了市场增长

不断提高的健康意识和有关单核细胞增多症的知识是推动单核细胞增多症诊断市场的关键因素。随着人们对健康问题(尤其是单核细胞增多症等独特传染病)的了解越来越多,他们往往会更积极地寻求诊断和治疗。随着健康素养的提高,人们能够更好地识别单核细胞增多症的症状,包括极度疲劳、发烧、喉咙痛和淋巴结肿大。早期发现对于有效管理也至关重要,因为它有助于预防并发症并缩短病程。通过互联网、社交媒体和教育活动获取信息使患者能够更确定地识别这些症状。因此,意识的提高导致对诊断测试的需求激增。

社交媒体和在线健康资源的兴起从根本上改变了个人获取健康信息的方式。Instagram、Twitter 和 Facebook 等平台是分享与单核细胞增多症相关的个人经历和专家见解的渠道。有影响力的人、健康专业人士和组织利用这些平台传播准确的信息、揭开疾病的神秘面纱并打击错误信息。因此,人们对单核细胞增多症的了解越来越多,从而增加了患者参与该疾病管理、诊断和治疗决策的机会。思维方式的转变使患者受益,并通过促进主动健康管理来增强整个医疗保健系统。

日益增强的健康意识也与全球医疗保健系统普遍推行的预防保健趋势相一致。对预防的重视推动了对单核细胞增多症诊断检测的需求。医疗保健提供者通过将常规筛查和教育材料纳入其实践来应对这一问题,从而进一步规范寻求诊断的过程。

即时诊断测试的发展为市场创造有利可图的机会

POC 检测可在患者护理现场或附近快速诊断,使医疗保健提供者能够立即做出临床决策并改善患者治疗效果。传统的实验室检测通常需要数小时或数天才能产生结果,这可能会延迟治疗并加重症状。相比之下,POC 检测可以在几分钟内提供结果,有助于及时干预。快速周转对于单核细胞增多症等疾病尤其重要,因为早期诊断可以减少并发症并提高患者舒适度。POC 检测可以在各种医疗保健环境中实施,包括门诊、急诊科和家庭护理环境。这种可及性在实验室基础设施有限的地区或医疗资源不足的农村地区尤其有益。以 POC 检测的形式将诊断能力更贴近患者可确保更多人及时得到诊断和适当的护理,从而扩大医疗保健服务的覆盖范围。此外,这种类型的检测可以促进更大的参与度,因为患者可以快速收到结果并与医疗保健提供者讨论下一步措施。

与传统实验室检测相比,POC 检测更具成本效益,因为它们不需要广泛的实验室基础设施,从而降低了医疗保健系统的总体成本。单核细胞增多症检测的经济实惠进一步推动了其对更广泛患者(尤其是医疗资源匮乏的人群)的可及性。生物传感器和微流体技术的最新进展正在推动更复杂的 POC 测试的发展,这些测试具有更高的灵敏度和特异性。这些创新确保了 POC 测试在检测单核细胞增多症方面的可靠性。提供 POC 检测试剂盒的市场参与者包括 SEKISUI Diagnostics(OSOM Mono 测试)、Abbott(Clearview Mono)和 Cardinal Health [Cardinal Health MONO(单核细胞增多症)II 快速测试]。因此,POC 测试的发展为单核细胞增多症诊断市场参与者带来了巨大的增长机会。

单核细胞增多症诊断市场报告细分分析

有助于得出单核细胞增多症诊断市场分析的关键部分是类型和最终用户。

  • 根据类型,单核细胞增多症诊断市场细分为爱泼斯坦巴尔病毒抗体检测、全血细胞计数检测和单核细胞增多症检测。单核细胞增多症检测细分市场在 2023 年占据了最大的市场份额。
  • 就终端用户而言,单核细胞增多症诊断市场分为医院、实验室和其他。医院部门在 2023 年占据了市场主导地位。

单核细胞增多症诊断市场份额按地区分析

单核细胞增多症诊断市场报告的地理范围主要集中在五个地区:北美、亚太地区、欧洲、南美和中美以及中东和非洲。就收入而言,北美在 2023 年占据了市场主导地位。预计在预测期内,它将主导全球市场。美国是世界上最大的单核细胞增多症诊断市场,预计在预测期内也将占据市场主导地位。美国市场的增长归因于技术进步、认识的提高以及对有效疾病管理策略的不断需求。根据美国国立卫生研究院的数据,美国每年记录约 125,000 例传染性单核细胞增多症病例。由于数量如此之多,该国对由爱泼斯坦-巴尔病毒 (EBV) 引起的单核细胞增多症的认识也在提高,这推动了对快速准确的诊断试剂盒、耗材和服务的需求。该国医疗服务提供商采用的各种检测方法包括基于抗体检测的血清学检测和专注于病毒 DNA 识别的分子检测。美国单核细胞增多症诊断市场的竞争格局由雅培实验室、罗氏诊断和西门子医疗等公司主导。这些公司投资于创新和合作,以增强其产品供应并扩大其市场占有率。

 

单核细胞增多症诊断市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响单核细胞增多症诊断市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的单核细胞增多症诊断市场细分和地理位置。

Mononucleosis Diagnostic Market
  • 获取单核细胞增多症诊断市场的区域特定数据

单核细胞增多症诊断市场报告范围

报告属性细节
2023 年的市场规模1.5144亿美元
2031 年市场规模2.2215亿美元
全球复合年增长率(2023 - 2031)4.9%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 单点试验
  • 爱泼斯坦-巴尔病毒
  • 全血细胞计数
按最终用户
  • 医院
  • 实验室
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培实验室
  • 阿灵顿科学公司
  • Bio-Rad 实验室公司
  • 康德乐公司
  • Meridian 生物科学公司
  • 积水诊断株式会社
  • 赛默飞世尔科技公司
  • QuidelOrtho 公司
  • F. 霍夫曼-罗氏有限公司
  • 凯杰公司

 

单核细胞增多症诊断市场参与者密度:了解其对业务动态的影响

单核细胞增多症诊断市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在单核细胞增多症诊断市场运营的主要公司有:

  1. 雅培实验室
  2. 阿灵顿科学公司
  3. Bio-Rad 实验室公司
  4. 康德乐公司
  5. Meridian 生物科学公司
  6. 积水诊断株式会社

免责声明上面列出的公司没有按照任何特定顺序排列。


Mononucleosis Diagnostic Market

 

  • 获取单核细胞增多症诊断市场顶级关键参与者概述

单核细胞增多症诊断市场新闻和最新发展

单核细胞增多症诊断市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是单核细胞增多症诊断市场见证的一个关键发展:

  • 全球领先的诊断检测解决方案和生命科学原材料供应商 Meridian Bioscience, Inc. 与 SD Biosensor, Inc. 和 SJL Partners LLC 宣布完成对 Meridian 的收购。(来源:Meridian Bioscience, Inc. 网站,2024 年 1 月)

单核细胞增多症诊断市场报告覆盖范围和交付成果

“单核细胞增多症诊断市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 范围涵盖的所有主要细分市场的全球、区域和国家层面的单核细胞增多症诊断市场规模和预测
  • 单核细胞增多症诊断市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
  • 详细的 PEST 和 SWOT 分析
  • 单核细胞增多症诊断市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及单核细胞增多症诊断市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the mononucleosis diagnostic market?

The market is expected to register a CAGR of 4.9% during 2023–2031.

What would be the estimated value of the mononucleosis diagnostic market by 2031?

The mononucleosis diagnostic market value is expected to reach US$ 222.15 million by 2031.

What are the future trends of the mononucleosis diagnostic market?

Advancements in molecular diagnostics are likely to bring new growth trends in the market in the coming years.

Which are the leading players operating in the mononucleosis diagnostic market?

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key players operating in the market.

What are the factors driving the mononucleosis diagnostic market growth?

The high risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are among the most significant factors fueling the market growth.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Mononucleosis Diagnostic Market

  1. Abbott Laboratories
  2. Arlington Scientific Inc
  3. Bio-Rad Laboratories Inc
  4. Cardinal Health Inc
  5. Meridian Bioscience Inc
  6. Sekisui Diagnostics LLC
  7. Thermo Fisher Scientific Inc
  8. QuidelOrtho Corp
  9. F. Hoffmann-La Roche Ltd
  10. QIAGEN NV
  11. Hologic Inc
  12. bioMerieux SA
  13. DiaSorin SpA
  14. Immunostics Inc.
  15. Launch Diagnostics Ltd
  16. Biorex Diagnostics
  17. ZEUS Scientific 

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.